Investigators of the WHO who visited a manufacturing plant of Sputnik V in the city of Ufa as part of the validation process of the vaccine found several problems, such as the traceability of the batches of the vaccine, the filling lines, the guarantee of sterilisation and the handling of cross-contamination hazards. Those observers didn’t question the vaccine itself but some environmental and sterilisation aspects in its fabrication. However, the WHO announced that it would paralyse the validation, not of the visited factory, but of the whole validation process of the Sputnik V at a global level.
The WHO team stated that the procedure didn’t fully adjust to what indicates the so-called ‘Good Manufacturing Practices’ or GMP. Not every country in the world sticks to this protocol, Russia being one of those who doesn’t, not because they don’t have quality standards but because their protocols are different, not necessarily better or worse.